Corcept is leading the way in the research and development of cortisol modulators, molecules that regulate cortisol activity at the glucocorticoid receptor (GR). To date, we have discovered more than 1,000 selective proprietary cortisol modulators. In 2012, we received FDA approval of Korlym® (mifepristone), the first approved treatment for hypercortisolism (Cushing’s syndrome). Today, our team and collaborators continue to unlock the possibilities of cortisol modulation as a way to treat serious diseases. With more than 30 ongoing studies across a wide range of disease areas, including endocrinology, oncology, metabolism, and neurology, we remain dedicated to advancing the possibilities of cortisol modulation. What began as a ripple of scientific truth is now poised to unleash a sea change of discovery representing a fundamental shift in the way we understand and treat disease. Come spend your summer working with passionate colleagues and inspirational leaders, all while gaining world-class experience in one of the fast-growing biotechs in the Bay Area. Corcept is seeking an intern to support the Pipeline & Portfolio Market Planning team in activities related to evaluating the opportunity for new indications across our portfolio. We are looking for an intern with excellent organizational, analytical, problem solving, and communication skills, who can perform detailed work accurately and in a timely manner. The intern hired for this position can expect to learn various facets of the planning, development, and commercialization of pharmaceuticals with the goal of leaving the internship with invaluable skills and industry knowledge.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Intern
Number of Employees
251-500 employees